Sun Pharmaceutical Industries Ltd. shareholder votes
The exchange lists 4 meetings for Sun Pharmaceutical Industries Ltd. with 20 resolutions put to shareholders; 0 failed and 1 passed with 10 percent or more against. The latest, a agm on 31 July 2026, put 8 resolutions to the vote, the lowest support 82.67% for.
| Meeting | Resolution | Kind | For | Against | Filing |
|---|---|---|---|---|---|
| AGM, 31 July 2026 | Adoption of Standalone Financial Statements along with reports of the Board of Directors and Auditors thereon for FY 2025-26 as approved and recommended by the Board. | Ordinary | 99.76% | 0.24% | NSE |
| AGM, 31 July 2026 | Approval for the appointment of Dr. Andreas Busch as an Independent Director for a term of five consecutive years, from 12 May 2026 to 11 May 2031 based on the approval of the NRC and of the Board of Directors. Dr. Busch brings over three decades of global pharmaceutical experience, particularly in research and development and innovation leadership, which will strengthen the Board���s capabilities in strategic oversight and support long-term value creation. | Special | 99.88% | 0.12% | NSE |
| AGM, 31 July 2026 | Approval for payment of commission to Independent Directors within the limits prescribed under the Companies Act, 2013. This approval is being sought pursuant to the requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as an enabling resolution. | Ordinary | 82.67% | 17.33% | NSE |
| AGM, 31 July 2026 | Approval to increase the maximum remuneration payable to Mr. Aalok Shanghvi, Whole-time Director, to ��15 crore per annum for the remaining tenure up to 31 May 2028. The revised remuneration will also be payable as minimum remuneration in the event of loss or inadequate profits, in accordance with applicable provisions. | Special | 98.12% | 1.88% | NSE |
| AGM, 31 July 2026 | Ratification of the remuneration of ��31.26 lakh per annum (plus taxes and expenses) payable to M/s. Narasimha Murthy & Co., Cost Accountants, as Cost Auditor for FY 2026���27. | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 31 July 2026 | Approval for Final Dividend of ��5/- per equity share for FY 2025-26, which if approved shall be paid to the Shareholders. | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 31 July 2026 | Approval for the appointment of Mr. Aalok Shanghvi, who retires by rotation and being eligible, has offered himself for re-appointment. | Ordinary | 92.63% | 7.37% | NSE |
| AGM, 31 July 2026 | Adoption of Consolidated Financial Statements along with the report of the Auditors thereon for FY 2025-26 as approved and recommended by the Board. | Ordinary | 99.84% | 0.16% | NSE |
| Postal Ballot, 8 May 2026 | Appointment of Ms. Satyavati Berera (DIN: 05002709) as an Independent Director | Special | 99.68% | 0.32% | NSE |
| Postal Ballot, 17 April 2026 | Ratification of the remuneration of the Cost Auditor for the financial year 2025-26 | Ordinary | 100.00% | 0.00% | NSE |
| Postal Ballot, 17 April 2026 | Re-appointment of Dr. Pawan Goenka (DIN:00254502) as an Independent Director | Special | 95.42% | 4.58% | NSE |
| Postal Ballot, 17 April 2026 | Alteration of Main Objects clause III (A) of the Memorandum of Association of the Company | Special | 100.00% | 0.00% | NSE |
| AGM, 31 July 2025 | Adoption of the audited standalone financial statements of the Company for the financial year ended March 31, 2025 and the reports of the Board of Directors and Auditors thereon. | Ordinary | 99.97% | 0.03% | NSE |
| AGM, 31 July 2025 | Appointment of KJB & Co LLP, Practising CompanynSecretaries, as the Secretarial Auditors of the Company | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 31 July 2025 | Appointment of Mr. Kirti Ganorkar (DIN: 10620142) asnthe Managing Director of the Company | Special | 99.59% | 0.41% | NSE |
| AGM, 31 July 2025 | Appointment of Mr. Dilip Shanghvi (DIN: 00005588) asnan Executive Director of the Company | Special | 98.72% | 1.28% | NSE |
| AGM, 31 July 2025 | Retirement of Mr. Sudhir Valia (DIN: 00005561), Non-nExecutive and Non-Independent Director | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 31 July 2025 | Appointment of Ms. Vidhi Shanghvi (DIN: 06497350) asna Whole-time Director | Special | 90.46% | 9.54% | NSE |
| AGM, 31 July 2025 | Declaration of Final Dividend of Rs. 5.50/- (Rupees Five andnpaise fifty only) per Equity Share of Rs. 1/- (Rupee Onenonly) each for the financial year 2024-25. | Ordinary | 100.00% | 0.00% | NSE |
| AGM, 31 July 2025 | Adoption of the audited consolidatednfinancial statements of the Company for the financialnyear ended March 31, 2025 and the report of thenAuditors thereon. | Ordinary | 99.97% | 0.03% | NSE |
An ordinary resolution passes with more than half the votes cast, a special resolution with more than three quarters. Percentages are the totals the company reported to the exchange across all shareholder classes. The exchange's list carries recent meetings, not the whole history.
Source
Voting results on nseindia.com for SUNPHARMA.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.